The available crystal structure for the complex between the Fc fragment of immunoglobulin G (IgG) and the neonatal Fc receptor (FcRn) was determined at low resolution and has no electron density for a large portion of the C H 2 domain of the Fc. Here, we use a well validated computational docking algorithm in conjunction with known crystallographic data to predict the orientation of C H 2 when bound to FcRn, and validate the predicted structure with data from site-speci®c mutagenesis experiments. The predicted Fc structure indicates that the C H 2 domain moves upon binding FcRn , such that the end-to-end distance of the bound Fc fragment is greater than it is in the crystal structure of isolated Fc. The calculated orientation of the bound C H 2 domain is displaced by an average of 6 A Ê from the C H 2 orientation in the structure of Fc alone, and shows improved charge complementarity with FcRn. The predicted effects of 11 speci®c mutations in Fc and FcRn are calculated and the results are compared with experimental measurements. The predicted structure is consistent with all reported mutagenesis data, some of which are explicable only on the basis of our model. The current study predicts that FcRn-bound Fc is asymmetric due to reorientation of the C H 2 domain upon FcRn binding, a rearrangement that would be likely to interfere with optimal binding of FcRn at the second binding site of the Fc homodimer.
The neonatal Fc receptor (FcRn) mediates the transfer of immunoglobulin G (IgG) molecules from maternal milk to the bloodstream of newborn mammals (Culbertson, 1938) , thus providing passive humoral immunity during the ®rst few weeks of life. In particular, FcRn binds IgG Fc under slightly acidic (pH 6.0 to 6.5) conditions, but not at neutral or higher pH (Rodewald, 1976; Rodewald & Kraehenbuhl, 1984; Simister & Mostov, 1989; . This ensures the effective unidirectional transport of maternal IgG from the apical side of intestinal epithelial cells (pH 6.0 to 6.5) to the bloodstream on the basolateral side (pH 7.4) by transcytosis (Rodewald & Kraehenbuhl, 1984) . In addition to its transport function, FcRn is a catabolic receptor that controls the lifetime of IgG in serum (Kim et al., 1994; Popov et al., 1996; Ghetie et al., 1996; Junghans & Anderson, 1996) .
Some understanding of the structural basis of IgG binding and dissociation has been obtained from crystal structures. A 2.2 A Ê crystal structure of FcRn (PDB entry 1FRU) shows that it is structurally homologous to major histocompatibility complex (MHC) class I molecules (Burmeister et al., 1994a) . Each consists of the light chain b2 microglobulin (b2m; Simister & Rees, 1985) non-covalently associated with a three domain heavy chain that is anchored to the membrane by a hydrophobic segment following the a3 domain. The heavy chains of MHC class I molecules and FcRn show sequence homology and a similar domain organization (Simister & Mostov, 1989) . In both cases the a1 and a2 domains consist of a single eight-stranded b sheet topped by two long a helices. However, in contrast to class I MHC molecules which bind and present peptides to cytotoxic T cells in a cleft bounded by the long a helices Townsend & Bodmer, 1989) , the FcRn cleft is closed (Burmeister et al., 1994a) and FcRn does not bind or present peptides or use its counterpart of the MHC peptide binding groove for any known function (Raghavan et al., 1993) .
IgG, the biological ligand of FcRn, is a large protein consisting of two identical heavy and light chain pairs arranged into two Fab arms and an Fc region formed by the carboxy-terminal halves of the heavy chains (Valentine & Green, 1967; Alzari et al., 1988; Poljak, 1975) . In the 2.8 A Ê crystal structure of Fc bound to fragment b of protein A (PDB entry 1FC2; Deisenhofer, 1981) , the two Fc chains are related by exact 2-fold symmetry, such that the two domains of one Fc chain (C H 2 and C H 3) have the same relation to the corresponding domains in the other chain.
The only experimental structure for the FcRn-Fc complex (PDB entry 1FRT; Burmeister et al., 1994b) was determined at low resolution (6.5 A Ê ), and in particular has almost no electron density for the C H 2 domain. However the overall arrangement of Fc and FcRn and the binding sites of the two molecules can be delineated. Thus we know that the binding site of FcRn lies at the edge of its two a-helices and the N-terminal portion of b2 m, and that of Fc is near the connection between the C H 2 and C H 3 domains (Burmeister et al., 1994b) .
The FcRn-Fc binding stoichiometry is 2:1 both in solution (Huber et al., 1993) and in the cocrystals (Burmeister et al., 1994b) . However, the packing in the cocrystals creates two distinct types of 2:1 FcRn-Fc complexes. In one, FcRn molecules dimerize through contacts between the a3 and b2m domains. This dimer binds one chain of Fc asymmetrically, with many more contacts with one (the primary) receptor than with the other (the secondary receptor). Each FcRn in this so-called lyingdown complex (Figure 1 top panel) is aligned with its longest dimension roughly parallel to the plane of the membrane. By contrast, the two FcRn molecules in the standing up 2:1 complex are oriented with their long axes roughly perpendicular to the membrane, and Fc is sandwiched between the two receptors (Figure 1 bottom panel) . In this complex, each Fc chain binds symmetrically to its FcRn partner and there is no contact between receptor molecules.
Mutations at the FcRn dimer interface and at the Fc interface with the second receptor in the FcRn dimer reduce the binding af®nity for IgG Vaughn et al., 1997) . In addition, a hybrid Fc with a functional FcRn binding site on one chain and a disrupted site on the other binds with normal af®nity to murine FcRn immobilized on a biosensor chip (Popov et al., 1996) , consistent with the lying down 2:1 FcRn-Fc complex in which the binding site on one of the Fc chains is not used. These results and biosensor studies that demonstrate that FcRn dimerization is required for high af®nity binding of IgG (Raghavan et al., 1995b) suggest that the lying down 2:1 complex is physiologically relevant. However, the structural details and energetics of the lying down complex are ambiguous since much of the C H 2 is disordered in the FcRn-Fc crystal structure (Burmeister et al., 1994b) . The two 2:1 complexes observed in 1FRT cocrystals oriented such that the plane of the membrane for cell surface FcRn would be horizontal. FcRn heavy chain, green; FcRn light chain, cyan; Fc, dark blue. Residues highlighted in red (FcRn heavy chain 219-224 and His250, His251) were mutated, resulting in reduced af®-nity for IgG . Top: Lying down 2:1 complex involving the FcRn dimer. The Fc molecule interacts asymmetrically with the receptor dimer, such that most of the contacts involve one of the FcRn molecules (the primary receptor). The receptor used in the docking calculation is de®ned as the primary FcRn along with the C H 3 domain of Fc with which it interacts. Bottom: Standing up 2:1 complex. Neither of the regions indicated by site-directed mutagenesis to affect IgG binding af®nity highlighted in red) are at the Fc interface or any other protein-protein interface. Figures 1 and 2 were generated using Molscript (Kraulis, 1991) and Raster-3D (Merritt & Murphy, 1994) .
One explanation for the disorder of C H 2 in the FcRn-Fc cocrystals involves the assumption that Fc changes its conformation upon binding to FcRn, becoming asymmetric such that only one of the FcRn-binding sites on the Fc homodimer is in the optimal conformation for receptor binding. Since the Fc molecules in the cocrystals are aligned along a crystallographic 2-fold axis, such deviation from perfect dyad symmetry would result in apparent disorder. In the absence of unambiguous information about the location of C H 2, Burmeister et al. (1994b) placed the CH3 domain as dictated by the electron density, then placed the C H 2 by assuming that the two Fc domains in the FcRn-Fc complex bear the same relation to each other as they do in the crystal structure of isolated Fc (Deisenhofer, 1981) .
Here, we pursue a more complex and potentially more informative approach to determine the orientation of the C H 2 domain. Speci®cally we use a previously validated computational docking strategy (Weng et al., 1996) to place C H 2 relative to C H 3 and the primary FcRn. Unlike in the FcRn-Fc cocrystals, the C H 2 domain in our computational approach is not constrained by 2-fold symmetry. We can therefore test for induced asymmetry in Fc upon receptor binding, and potentially gain more insight into the high af®nity interaction between FcRn and Fc.
For docking purposes, the``receptor'' is de®ned as the primary FcRn together with the interacting C H 3 domain of Fc as in crystal structure 1FRT (Figure 1 , top panel) and the ligand is the C H 2 domain. The secondary FcRn (Figure 1 , top panel) was not included as part of the receptor in order to prevent bias in the calculations towards the lyingdown 2:1 complex. The loop between C H 2 and C H 3 (residues 339 to 342) was deleted during the docking procedure, but a 14 A Ê cutoff between residue 338 and 343 was used to ®lter out C H 2 orientations that would be unreachable from C H 3.
Using the low resolution crystal structure 1FRT, ligand residues with at least one atom within 6 A Ê of the receptor (24 residues of C H 2) and receptor residues having one or more atoms within 6 A Ê of the ligand were identi®ed as the binding site residues. This resulted in the receptor site comprised of 18 residues of the heavy and six residues of the light (b2m) chain of the primary FcRn, and 11 residues of C H 3.
The program DOCK3.0 (Shoichet & Kuntz, 1991 ) was used to replace the atoms of the binding site residues of the ligand and the receptor with sets of spheres and to generate possible orientations of ligand with respect to the receptor. 26,432 C H 2 orientations were generated. Of these, orientations of the ligand that placed it in the excluded volume of the FcRn-C H 3 receptor were eliminated. Speci®-cally, no more than 20 clashes between binding site residues and no more than 30 clashes overall were allowed during docking. Of the remaining orientations, we eliminated all those with fewer than 220 favorable contacts between the ligand and the receptor binding site residues, as well as those that placed residue 338 (the ®rst residue of the loop between C H 2 and C H 3) farther than 14 A Ê from residue 343 (the last residue of the loop). Clashes and favorable contacts are as de®ned in DOCK3.0 (Shoichet & Kuntz, 1991) . This resulted in 40 C H 2 orientations and the orientation in crystal structure 1FRT was not among them. The 40 C H 2 orientations and the 1FRT orientation were subjected to a 60 step Adopted Basis Newton ±Raphson (ABNR) energy minimization, with parameters taken from Version 19 of the CHARMM potential (Brooks et al., 1983) , in order to remove all van der Waals clashes.
The energy minimized structures were ranked using empirically calculated binding free energy (Vajda et al., 1994; Weng et al., 1996) between Fc and the primary FcRn (ÁG 1 ), as well as that between Fc and the dimerized FcRn (ÁG 2 ). ÁG 1 is de®ned as follows:
where ÁG s 1 and ÁS sc 1
are the desolvation free energy and side-chain entropy loss when Fc binds to the primary FcRn. E el 1 , the electrostatic interaction energy between Fc and the primary FcRn, is evaluated using
is the difference of the C H 2 À C H 3 electrostatic interaction energies between each docked C H 2 orientation and the Deisenhofer C H 2 orientation. We assume that Fc exists in the conformation observed in the Deisenhofer crystal structure (Deisenhofer, 1981) when it is not bound to FcRn. Therefore ÁE el CH2 À CH3 is the internal energy change of Fc upon binding to FcRn. Since the 41 structures were minimized by a 60-step ABNR procedure prior to free energy evaluation, there is a slight variation (about 1 kcal/mol) in E el 1 À CH3 (the electrostatic interaction energy between C H 3 and the primary FcRn), with different C H 2 orientations.
All of the E el terms are calculated with version 19 of the CHARMM force ®eld (Brooks et al., 1983) using a distance-dependent dielectric coef®cient e 4r and a non-bonded cutoff of 15 A Ê . During this calculation, histidine residues are assumed to be positively charged (protonated), because there is no observable binding at pH > 7.5 . The desolvation free energy ÁG s is calculated as
where the transfer free energies of the complex (ÁG tr rl ), the receptor (ÁG tr r ), and the ligand (ÁG tr l ) are obtained by a linear combination of the solvent accessible areas weighted by atomic solvation parameters (Eisenberg & McLachlan, 1986; Vajda et al., 1994) . Finally, the side-chain entropy loss ÁS sc is assumed to be proportional to its loss in solvent Structure Determination of Fc-FcRn Complex accessible surface area (Pickett & Sternberg, 1993) , and is calculated as described elsewhere (Vajda et al., 1994) .
Since we are only interested in comparing different C H 2 orientations of the same FcRn-Fc complex and calculating differential binding free energies of mutations, we will ignore translational, rotational, vibrational and cratic (or dilutional) free energy changes, a constant to a ®rst approximation (Novotny et al., 1989; Vajda et al., 1994) . Thus the value we get from equation (1) is a target function rather than a full free energy.
The free energy change for binding Fc with each C H 2 orientation to dimerized FcRn ÁG 2 can be calculated similarly by including the electrostatic interaction energy between the secondary FcRn and Fc, and calculating the desolvation free energy (ÁG s 2 ) and side-chain entropy loss (ÁS sc 2 ) in the presence of both FcRn molecules. That is, when doing calculations on the lying-down 2:1 complex, we assume that FcRn dimerization is required for optimal Fc binding (Raghavan et al., 1995b) . The orientation of the secondary FcRn is taken from the lying-down complex in crystal structure 1FRT (Burmeister et al., 1994b) .
The four-residue loop between C H 2 and C H 3 is ignored in the binding energy calculation for two reasons: (1) Among human, murine and rat Ig subtypes, this loop is highly variable (only position 341 is conserved as Gly). Therefore we can assume that this loop is¯exible enough to have no internal energy difference between different C H 2 placements as long as the distance between residues 338 and 343 is less than 14 A Ê . (2) This loop is more than 17 A Ê away from FcRn and therefore it does not contribute directly to binding.
Of the 41 Fc structures, The best one had a binding free energy of À31 kcal/mol with the primary FcRn (ÁG 1 of equation (1)) and of À40 kcal/mol with the FcRn dimer (ÁG 2 ). This is the predicted structure which we will call FcP. The coordinates of FcP and its bound FcRn dimer have been deposited in the Brookhaven Data Bank (PDB entry 2FRT). Energy values for FcP are lower than those obtained when Fc is placed in the orientation reported in the structure 1FRT (here referred to as FcX); the latter values are À26.2 kcal/mol and À22.4 kcal/mol for interactions with the monomeric (ÁG 1 ) and dimerized (ÁG 2 ) FcRn, respectively. Figure 2 is a ribbon diagram of dimerized FcRn and a bound Fc chain in both its crystal structure 1FRT (C H 2X in yellow) and predicted (C H 2P in red) orientations. The conformation of the fourresidue loop between C H 2P and C H 3 (residues 339 to 342; highlighted in dark purple in Figure 2 ) is calculated using a loop closure algorithm with CONGEN (Bruccoleri & Novotny, 1992) . C H 2P and C H 2X are similar to each other in the region close to the C H 3 domain, but differ in the region far from it, resulting in a 6 A Ê root mean square deviation (RMSD) for all C H 2 atoms. In our prediction the C H 2 domain is pushed closer to both FcRn molecules. It is also slightly rotated about its own long axis and around the hinge between the two domains. Thus the joint between the two domains is more extended in FcP than in FcX; the distance between the C terminus of the C H 2 domain and the N terminus of the C H 3 domain is 13 A Ê in FcP and 10 A Ê in FcX. The surface area (Lee & Richards, 1971 ) of the C H 2 domain buried in binding to the Only one chain of Fc is shown along with an FcRn dimer as in the lying down 2:1 complex (Burmeister et al., 1994b) ; the orientation shown is rotated by about 30 around the horizontal axis from the view shown in Figure 1 , top panel. The crystal structure (C H 2X, yellow) and predicted (C H 2P, red) orientations of the C H 2 domain are shown. The C H 3 domain is shown in its orientation in the crystal structure 1FRT. Note that C H 2P and C H 2X superimpose well in regions close to the C H 3 domain but diverge in the distal regions. The four-residue loop connecting C H 2 and C H 3 domains is highlighted in dark purple. The¯exi-bility of this loop allows the displacement of the C H 2 domain upong FcRn binding. The FcRn residues 219 to 224 (in magenta) and His250, His251 (in gold), which are important for Fc binding , are in direct contact with C H 2P, but not with C H 2X. The coordinates of FcP and its bound FcRn dimer has been deposited in the Brookhaven Data Bank (PDB entry 2FRT).
FcRn dimer is 1272 A Ê 2 in FcP compared to 695 A Ê 2 2 in FcX. 18 residues of the C H 2 domain are within 5.8 A Ê (the sum of diameters of a water molecule (2.8 A Ê ) and of an average non-hydrogen atom in a protein (3.0 A Ê )) of the heavy chain of the secondary FcRn when Fc is in the FcP orientation. In the FcX orientation, only three of these residues (E272, H285, and T286) are within 5.8 A Ê of the secondary FcRn. 13 residues of the secondary FcRn heavy chain are within 5.8 A Ê of the C H 2 domain in its predicted C H 2P orientation. Once again, there are only three secondary FcRn residues (L219, A220, and K245) within 5.8 A Ê of the C H 2X orientation. Of the FcRn residues close to C H 2X, FcRn L219 and A220 are within 5.8 A Ê of Fc E272 and FcRn K245 is within 5.8 A Ê of Fc H285 and T286. However, since H285 is positively charged, the electrostatic repulsion between this residue and K245 of FcRn results in a 3.28 kcal/mol unfavorable electrostatic interaction between C H 2X and the secondary FcRn. This could be an artifact, since H285 and K245 might avoid each other through changes in sidechain conformation. This contact is also present between the secondary FcRn and C H 2P. Therefore, by the same argument, the electrostatic interaction between C H 2P and the secondary FcRn could be more favorable than the À8 kcal/mol that we calculate here. In any case, the poor charge complementarity of C H 2X with the secondary FcRn suggests that C H 2X is not the optimal orientation.
Analysis of the 40 Fc structures that we generate provides additional evidence that FcP is a better candidate than FcX for the C H 2 orientation. Figure 3 A and B shows ÁG 1 and ÁG 2 (free energies as calculated in equation (1) for interaction with monomeric FcRn, ÁG 1 , and dimeric FcRn, ÁG 2 ) for each structure, plotted against the RMSD of each of the 41 C H 2 structures from C H 2P. The correlation coef®cients are 0.84 for ÁG 1 and 0.91 for ÁG 2 . This should be compared to the much weaker correlation obtained when ÁG 1 and ÁG 2 are plotted against the RMSD from C H 2X (Figure 3C and D; correlation coef®cients are 0.39 and 0.31, respectively).
We also calculated the effects of the 11 FcRn and Fc mutations for which binding data are available (Table 1 ). All of the Fc mutants are near the C H 2-C H 3 interface and mutations in FcRn residues map close to Fc residues in that region. Since the FcX and FcP structures are similar in this region, these results do not qualitatively discriminate between them. We therefore used the FcP structure, assum- Vaughn et al. (1997) .
a EE is the double mutant E132Q E135Q. b EED is the triple mutant E132Q E135Q D137N. c 84-86 is the triple mutant N84G Q85Y I86Y. The program CONGEN (Bruccoleri & Novotny (1992) was used to search for the lowest energy conformations of the two mutant Tyr side-chains at positions 85 and 86.
ing all histidine residues to be charged (corresponding to pH 6.0), and calculated their binding af®nity ÁG 2 , de®ned as in Figure 3 .
Measured binding free energy changes ÁÁG measured are available for seven mutants (Table 1) : two marginally favorable and ®ve disruptive (Vaughn et al., 1997) . For all of these, the calculated free energy changes (ÁÁG 2 (Medesan et al., 1997) . (2) The mutant H310A of mIgG1 has markedly decreased intestinal transcytosis (Kim et al., 1994) . (3) When C H 2 residues 309 to 311 of human IgG4 (hIgG4) are changed from the sequence LHQ to GGG, its binding af®nity to FcRn decreases (K D increased from 21 nM to 1.7 mM; . Our calculated ÁÁG 2 of 7.1 kcal/mol agrees well with these results. The sequence of positions 309 to 311 of the rat IgG1 which we used is LHQ, the same as that of hIgG4. According to our calculation, residue 309L contributes À3.0 kcal/mol and 311Q contributes À0.5 kcal/mol to the binding.
Experiments suggest that the other C H 2 mutation (I253A) also reduces binding. (1) mIgG1 Fc mutant I253A is 20% as effective as wild-type Fc in competing for FcRn binding (Medesan et al., 1997) . (2) The mIgG1 Fc mutant I253A has lowered intestinal transfer (Kim et al., 1994) . (3) Mutating residues 252 to 254 of hIgG4 from the sequence MIS to GGG decreased the binding af®nity (K D increased from 21 nM to 1.9 mM; . These experiments agree well with the calculated 3.1 kcal/mol ÁÁG 2 of I253A mutant versus. the wild-type. The sequence of positions 252 to 254 of the rat IgG1 (which we use for our model) is actually TLT. According to our calculation, residues 252T and 254T contribute favorably to the binding, À1.1 and À4.8 kcal/mol, respectively.
The C H 3 mutant H433A shows lowered binding af®nity for FcRn and hindered intestinal transcytosis in mice (Kim et al., 1994; Medesan et al., 1997) . Our calculation for this mutant showing a ÁÁG 2 of 5.1 kcal/mol, is consistent with this experimental ®nding.
Residues 219 to 224 of the a3 domain of the FcRn (highlighted with red color in Figure 1 , and with meganta color in Figure 2 ) correspond to the CD8-binding loop of the class I MHC molecules . Mutating these residues from the sequence in FcRn (LASGSG) to that in class I MHC molecules (EDQTQD) reduces the binding af®nity two to sevenfold . Since six positions were changed to residues more complicated than Ala, it is not straightforward to correlate the change in binding af®nity to free energy contributions from individual residues in this loop. Nevertheless, we note that L219, A220 and S221 show favorable contributions to binding (À3.3, À1.0, and À0.6 kcal/mol, respectively) in the FcP structure. By contrast in the FcX structure, only L219 has a small favorable contribution of À1.1 kcal/mol. Even this contribution may be spurious since it arises mostly from the hydrophobic contributions of L219, which is solvent exposed in the unbound state and buried by E272 of Fc in the bound state. Such a contact between a Glu and a Leu would probably be avoided through side-chain con®gurational changes leading to the exposure of L219 in the bound state as well.
H250Q H251N (represented with red stick model in Figure 1 , and with gold stick model in Figure 2 ) in the FcRn heavy chain causes a sixfold reduction in binding af®nity to Fc . This is consistent with the C H 2P orientation in which H251 of the secondary FcRn heavy chain is in close proximity to the C H 2 domain. In the C H 2P structure, H251 contributes À1.0 kcal/mol to the binding af®nity in the His state and 0.2 kcal/mol in the His 0 state. By contrast, for the C H 2X structure, neither H250 nor H251 is in the vicinity of Fc, and their residue contributions are therefore zero. Previously the effects of mutating H250 and H251 were argued to be due to a destabilization of the FcRn dimer, which is required for high af®nity binding of IgG . However, such dimerization increases the binding af®nity of Fc if it is in the FcP, but not in the FcX con®guration. With FcX, hindered dimerization due to these mutations should not cause an increase in binding af®nity since we calculate the ÁG of FcX bound to an FcRn monomer to be marginally more favorable than that of FcX to an FcRn dimer.
Here we used a previously developed and validated binding free energy target function (Vajda et al., 1994; Weng et al., 1996) to calculate the structure of one of the two chains of IgG Fc bound to FcRn. Each chain has two domains (C H 2 and C H 3) and rearrangements may occur among them during complex formation. The novelty in our approach is that such rearrangements are explicitly allowed. Thus, instead of treating the whole Fc chain as a rigid body, as is done in typical docking calculations, we only assume that the individual Fc domains act as rigid bodies. Speci®cally, since the position of the C H 3 domain can be ascertained relatively well from the FcRn-Fc cocrystal structure 1FRT, we took the location of the C H 3 domain as given, ignored the intervening loop connecting the C H 3 and C H 2 domains and docked the latter. Only the primary FcRn was used in the docking calculation, since we did not want to add an inherent bias towards the lying down 2:1 complex (Burmeister et al., 1994b) . The docking resulted in a ®nal Fc structure in which the domains are rearranged with respect to the starting model. The C H 2 domain is now moved toward the primary FcRn and rotated. As a result, C H 2 has a favorable close contact with the secondary FcRn when the latter is re-introduced according to the lying down 2:1 complex in the FcRn-Fc cocrystals 1FRT.
The displacement of the C H 2 in the FcRn-binding Fc chain also indicates that an Fc homodimer would not be 2-fold symmetric when bound to FcRn, and only one chain would be expected to retain an optimal site for FcRn binding. Placing an asymmetric Fc on a crystallographic 2-fold symmetry axis would result in disorder of any portion that does not obey dyad symmetry, which could explain the lack of electron density for much of the C H 2 domain in the Fc-FcRn cocrystals.
Since a high resolution structure is not yet available for this complex, testing the predicted C H 2 orientation is a non-trivial matter. Speci®cally, the X-ray structure 1FRT shows almost no electron density for the C H 2 domain in the region far from C H 3. It is in this region that our prediction (C H 2P) differs from the C H 2X orientation of the crystal structure giving an overall RMSD of 6 A Ê for this domain. We therefore tested our prediction on the basis of its consistency with data from site-directed mutagenesis experiments. We believe the predicted FcP structure is correct based on the reasons summarized below:
(1) The calculated free energy target function has a lower value for the proposed structure than for the crystal structure 1FRT.
(2) The opposing molecular surfaces of Fc and secondary FcRn show poor charge complementarity in the C H 2X orientation. Indeed, the calculated ÁG for C H 2X orientation bound to monomeric FcRn is marginally lower than that for C H 2X bound to dimeric FcRn. C H 2P, on the other hand, shows much better binding to the FcRn dimer, consistent with the experimental result that Fc binds more than 100-fold stronger to an FcRn dimer than to a monomer (Raghavan et al., 1995b) . Also, C H 2P orientation explains the effects on binding af®nity of the mutations involving H250, H251 and the CD8 loop of FcRn.
(3) The RMSDs of the different tentative C H 2 orientations (generated by the DOCK program, Shoichet & Kuntz, 1991) from FcP are well correlated to their calculated values of the binding free energy target functions ÁG 1 and ÁG 2 ( Figure 3A and B). Thus as structures move away from C H 2P, both target functions ÁG 1 and ÁG 2 rise on average. This strengthens the notion that C H 2P is the global minimum of the binding free energy target function, or the correct structure. If the RMSDs are calculated with respect to C H 2X, correlations with both ÁG 1 and ÁG 2 are poor ( Figure 3C and D) .
In these comparisons, it is important to realize that in our free energy target function, calculations of hydrophobicity are more reliable than those of electrostatics. The latter are prone to overestimation because small changes in the positions of charged atoms can lead to large changes in the total coulombic electrostatic interaction energy. Thus, when a charged residue of a salt bridge is mutated to a neutral residue, the binding free energy changes by a large amount. And when a buried hydrophobic residue is mutated, the binding free energy changes are relatively smaller in magnitude. For example, if we compare two C H 2 mutants I253A and H310A in Table 1 , the calculated ÁÁG 2 values are much more positive for H310A (7.1 kcal/mol) than for I253A (3.1 kcal/ mol) even though experiments show that the binding af®nities for these two mutants are about the same Popov et al., 1996) . The overestimated ÁÁG 2 for H310A could be because H310 is not completely protonated at pH 6.0. It could also due to the tendency of our binding free energy function to overestimate charge-charge interactions.
During our docking calculations, only the primary FcRn was part of the receptor and the secondary FcRn was placed as in the 1FRT crystal structure so that we did not inherently bias our docking toward the lying-down complex. We ®nd that the C H 2 orientation which has the most favorable interaction with the primary FcRn (lowest ÁG 1 ), C H 2P, also has the most favorable interaction with dimerized FcRn (lowest ÁG 2 ). This natural emergence of the lying down 2:1 complex supports the validity of the C H 2P orientation.
The evidence we present here supports the hypothesis that FcRn-bound Fc is asymmetric due to reorientation of the C H 2 domain upon FcRn binding. As a result of this reorientation, the hinge between the C H 2 and C H 3 domains is more extended in the Fc chain bound to FcRn. To accommodate this extension, it is likely that the partner Fc chain would have to¯ex, making the angle between its two domains more acute. This sort of rearrangement would be likely to interfere with optimal binding of FcRn on the partner Fc chain, resulting in a lying down 2:1 complex in which the FcRn binding site on one of the Fc polypeptide chains is not used (Figure 1, top panel) . Interestingly, a number of other Fc receptors appear to interact with only one Fc chain, as suggested by experiments demonstrating 1:1 stoichiometry for IgG interacting with FcgRI (Koolwijk et al., 1989) and FcgRIII (Ghirlando et al., 1995) , and IgE interacting with FceRI (Robertson, 1993) . Taken together, these results suggest that Fc asymmetry is a common theme in Fc-Fc receptor interactions (reviewed by Raghavan & Bjorkman, 1996) .
Although the predominant FcRn-Fc species in solution at mM concentrations is a 2:1 receptorligand complex (L.M. Sa Ânchez & P.J.B., unpublished results), higher order multimers with an overall 2n:n stoichiometry form in the FcRn-Fc cocrystals (Huber et al., 1993; Burmeister et al., 1994b) . These higher order oligomers result from a combination of the interactions that form the lying down and standing up 2:1 complexes, demonstrating that both chains of Fc can interact with FcRn at the very high protein concentrations in the cocrystals (mM). The observed disorder of the Fc C H 2 domains in the cocrystals can be explained if only one Fc chain contains an optimal FcRn binding site, as implied by the results of the present study. It has been suggested that IgG-induced dimerization of FcRn, followed by creation of networks that include both the standing up and lying down 2:1 higher order oligomers, signals the initiation of transcytosis in vivo (Raghavan & Bjorkman, 1996) . Under physiological conditions, use of the suboptimal FcRn binding site on Fc resulting in higher order oligomers might occur under conditions of high local protein concentration, such as when FcRn dimers on one membrane are bridged by IgG molecules to FcRn dimers on a closely spaced parallel adjacent membrane (Burmeister et al., 1994b; Raghavan & Bjorkman, 1996) . The present study addresses this hypothesis by providing a plausible molecular mechanism to account for induced Fc asymmetry upon binding to FcRn, and provides additional evidence that high af®nity binding requires FcRn dimerization.
